Summary
PFIZER MANUFACTURING BELGIUM has been active since 1960 and the Belgian State Gazette contains no insolvency or warning signals. The 2019 annual accounts show equity of €1.01B and a net result of €43.63M. The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
No current score
Figures too old
The available figures for FY 2019 are too old to assess current financial health.
Axes, FY 2019 · tick = 2018
Profitability81=
Solvency81▼-5
Growth85
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
about 14% more bankruptcies
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 30-11-2025 was due by 30-06-2026 and was filed on 02-06-2026, 28 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
28 d early
2024
35 d early
2023
34 d early
2022
31 d early
2021
52 d early
2021
27 d early
2020
47 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-11-2026 and is due by 30-06-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today30-11-2026 close30-06-2027 deadline
Financials · fiscal year 2019, full schema, statutory accounts
Turnover
€514.62M▲ 28.2%
2018 · €401.41M
2018: €401.41M
2019: €514.62M▲ +28.2% vs 2018
2018 → 2019
EBIT margin
12.2%▼ 0.2pp
2018 · 12.3%
2018: 12.3%
2019: 12.2%▼ -1.5% vs 2018
2018 → 2019
Net result
€43.63M▲ 34.0%
2018 · €32.56M
2018: €32.56M
2019: €43.63M▲ +34.0% vs 2018
2018 → 2019
Working capital
€-356.94M▼ 27.2%
2018 · €-280.53M
2018: €-280.53M
2019: €-356.94M▼ -27.2% vs 2018
2018 → 2019
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20182019Trend
Turnover€401.41M-€514.62M▲ 28.2%
2018: €401.41M
2019: €514.62M▲ +28.2% vs 2018
Equity€969.64M-€1.01B▲ 4.5%
2018: €969.64M
2019: €1.01B▲ +4.5% vs 2018
Operating result€49.52M-€62.56M▲ 26.3%
2018: €49.52M
2019: €62.56M▲ +26.3% vs 2018
Net result€32.56M-€43.63M▲ 34.0%
2018: €32.56M
2019: €43.63M▲ +34.0% vs 2018
Result per fiscal year
Operating resultNet result
The operating result rises in 2019; 2019 is 26% above 2018.
Balance-sheet composition
2019 in colour, 2018 as the grey bar beneath
Assets €1.82B
Fixed assets
€1.38B ▲ 9.4%
Current assets
€442.10M ▲ 33.9%
Equity and liabilities €1.82B
Equity
€1.01B ▲ 4.5%
Provisions
€7.48M ▼ 23.4%
Debt
€799.96M ▲ 30.9%
Debt's share of the balance-sheet total rises from 38.4% to 43.9%. Equity and debt are higher.
Key figures and ratios
EBITDA
€132.41M▲
2018 · €108.85M
Cash flow
€113.49M▲
2018 · €91.89M
Current ratio
0.55▲
2018 · 0.54
Quick ratio
0.24▲
2018 · 0.19
ROE
4.3%▲
2018 · 3.4%
ROA
2.4%▲
2018 · 2.0%
Interest coverage
129.88▼
2018 · 624.69
Debt ≤ 1 year
€799.04M▲
2018 · €610.77M
Income taxes
€18.42M▲
2018 · €17.29M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2019 against 2018 · 28 lines
Balance sheet
Code20182019
Assets
Total assets20/58€1.59B€1.82B▲
Fixed assets21/28€1.26B€1.38B▲
Intangible fixed assets21€6.01M€11.56M▲
Tangible fixed assets22/27€584.98M€697.95M▲
Financial fixed assets28€669.10M€669.10M=
Current assets29/58€330.24M€442.10M▲
Stocks and contracts in progress3€214.30M€248.23M▲
Amounts receivable within one year40/41€115.52M€192.52M▲
Cash at bank and in hand54/58€98k€197k▲
Equity and liabilities
Total equity and liabilities10/49€1.59B€1.82B▲
Equity10/15€969.64M€1.01B▲
Contributions10/11€285.05M€285.05M=
Reserves13€46.67M€66.84M▲
Profit (loss) carried forward14€252.27M€295.90M▲
Provisions and deferred taxes16€9.77M€7.48M▼
Amounts payable17/49€610.91M€799.96M▲
Amounts payable within one year42/48€610.77M€799.04M▲
Trade debts44€150.39M€119.38M▼
Income statement
Code20182019
Turnover70€401.41M€514.62M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€59.33M€69.86M▲
Operating profit (loss)9901€49.52M€62.56M▲
Recurring financial income75€1.29M€3.23M▲
Recurring financial charges65€959k€3.74M▲
Debt charges650€174k€1.02M▲
Profit (loss) for the period before taxes9903€49.85M€62.05M▲
Income taxes67/77€17.29M€18.42M▲
Profit (loss) for the period9904€32.56M€43.63M▲
Profit (loss) for the period to be appropriated9905€32.56M€43.63M▲
Accounts by statement
| Line | 2018 | 2019 | Change |
|---|---|---|---|
| Turnover70 | €401.41M | €514.62M | ▲ 28.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €59.33M | €69.86M | ▲ 17.7% |
| Operating profit (loss)9901 | €49.52M | €62.56M | ▲ 26.3% |
| Recurring financial income75 | €1.29M | €3.23M | ▲ 151% |
| Recurring financial charges65 | €959k | €3.74M | ▲ 290% |
| Debt charges650 | €174k | €1.02M | ▲ 485% |
| Profit (loss) for the period before taxes9903 | €49.85M | €62.05M | ▲ 24.5% |
| Income taxes67/77 | €17.29M | €18.42M | ▲ 6.6% |
| Profit (loss) for the period9904 | €32.56M | €43.63M | ▲ 34.0% |
| Profit (loss) for the period to be appropriated9905 | €32.56M | €43.63M | ▲ 34.0% |
| Line | 2018 | 2019 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €1.59B | €1.82B | ▲ 14.5% |
| Fixed assets21/28 | €1.26B | €1.38B | ▲ 9.4% |
| Intangible fixed assets21 | €6.01M | €11.56M | ▲ 92.5% |
| Tangible fixed assets22/27 | €584.98M | €697.95M | ▲ 19.3% |
| Financial fixed assets28 | €669.10M | €669.10M | = |
| Current assets29/58 | €330.24M | €442.10M | ▲ 33.9% |
| Stocks and contracts in progress3 | €214.30M | €248.23M | ▲ 15.8% |
| Amounts receivable within one year40/41 | €115.52M | €192.52M | ▲ 66.7% |
| Cash at bank and in hand54/58 | €98k | €197k | ▲ 100% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €1.59B | €1.82B | ▲ 14.5% |
| Equity10/15 | €969.64M | €1.01B | ▲ 4.5% |
| Contributions10/11 | €285.05M | €285.05M | = |
| Reserves13 | €46.67M | €66.84M | ▲ 43.2% |
| Profit (loss) carried forward14 | €252.27M | €295.90M | ▲ 17.3% |
| Provisions and deferred taxes16 | €9.77M | €7.48M | ▼ 23.4% |
| Amounts payable17/49 | €610.91M | €799.96M | ▲ 30.9% |
| Amounts payable within one year42/48 | €610.77M | €799.04M | ▲ 30.8% |
| Trade debts44 | €150.39M | €119.38M | ▼ 20.6% |
| Line | 2018 | 2019 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €32.56M | €43.63M | ▲ 34.0% |
| + Depreciation and write-downs630 | €59.33M | €69.86M | ▲ 17.7% |
| Operating cash flow (approximation) | €91.89M | €113.49M | ▲ 23.5% |
| Investment in fixed assets (approximation) | - | €-188.39M | - |
| Change in cash | - | €99k | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
26-05
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
27-05
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
30-05
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
09-06
NBB filing
Annual accounts filed
fiscal year 2021 · consolidated
03-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
14-06
NBB filing
Annual accounts filed
fiscal year 2020 · consolidated
14-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
03-06
NBB filing
Annual accounts filed
fiscal year 2019 · consolidated
28-05
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
30-11
Financial
Equity above €1000MEq €1.01B ▲4.5%
2 profitable years in a row build equity to €1.01B.
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 46 acts read
About the unread acts
We know of 46 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
46 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Puurs-Sint-Amands · 6 establishment units since 1960
Ground area
27.5 ha
Building footprint
12.9 ha
Volume, LiDAR
285,956 m³
5 parcels, Flanders · tallest building 13.9 m, ±4 floors. Linked by address, not a title deed.
6 establishment units
PFIZER manufacturing Belgium NV
since 19602.006.278.417
PFIZER MANUFACTURING BELGIUM NV
since 20172.261.678.724
PFIZER MANUFACTURING BELGIUM NV
since 20172.261.678.823
PFIZER MANUFACTURING BELGIUM NV
since 20172.261.678.922
PFIZER MANUFACTURING BELGIUM NV
since 20232.341.753.907
PFIZER MANUFACTURING BELGIUM
since 20232.345.938.268
5 parcels
Flanders
5
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12030D0050/00F000 | Flanders | 11.5 ha | 1 · 7.0 ha | - |
| 12008A0021/00M000 | Flanders | 8.0 ha | 1 · 3.0 ha | - |
| 12030D0035/00S000 | Flanders | 3.9 ha | 1 · 1.3 ha | 11.1 m · 3 fl. |
| 12032C0431/00C000 | Flanders | 3.0 ha | 1 · 1.3 ha | 13.9 m · 4 fl. |
| 12030D0036/00S000 | Flanders | 9,712 m² | 1 · 3,056 m² | 10.3 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
5 of 5 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Ownership & control
2 parent companies · 1 subsidiaryControl over this companyparent company per the LEI register2
Pharmacia International B.V.
Capelle Aan Den IJssel, Netherlands
PFIZER INC.
Wilmington, United States · indirect
controls
PFIZER MANUFACTURING BELGIUMBE 0400.778.165
controls
Where this company holds controlsubsidiary per the LEI register1
Puurs-Sint-Amands · LEI lapsed
Public money · subsidies and aid
Flemish government
2022 to 2025 · 23 entries · 3,842,137 EUR awarded · 942,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 10 | 709,082 EUR | 337,495 EUR |
| 2024 | 4 | 2,526,400 EUR | 120,095 EUR |
| 2023 | 4 | 190,935 EUR | 288,641 EUR |
| 2022 | 5 | 415,720 EUR | 195,769 EUR |
Schemes
Subsidie voor opdrachten Vlaamse Regering transitieprojecten klimaat, energie, circulaire economie en industrie 4.0
Onderzoeksproject
Ecologiepremie+
Vlaams opleidingsverlof (VOV)
Ontwikkelingsproject
Show 3 more
Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel)
Strategisch onderzoekscentrum ICON project (SOC-ICON)
Subsidies bevordering duurzaam woon-werkverkeer ikv Pendelfonds
European Union, budget
2023 to 2024 · 2 entries| Year | Entries | awarded |
|---|---|---|
| 2024 | 1 | 0 EUR |
| 2023 | 1 | 0 EUR |
Projects
MANUFACTURING OF MRNA-BASED VACCINES
Recognitions · licences · registrations
Food safety, FASFC
3 sitesPuurs-Sint-Amands2.006.278.417
Puurs-Sint-Amands2.261.678.823
Puurs-Sint-Amands2.345.938.268
Care and welfare
1 servicePfizer
Legal Entity Identifier
54930038UMTICLMB5I80
Similar companies · same sector, comparable size
UCB BIOPHARMA
BE 0543.573.053
Anderlecht · Eq €1.18B
GENZYME FLANDERS
BE 0475.955.046
Geel · Eq €782.05M
BAXALTA BELGIUM MANUFACTURING
BE 0563.700.454
Lessines · Eq €533.78M
Mithra Pharmaceuticals
BE 0466.526.646
Liège · Eq €290.23M
Organon Heist
BE 0412.581.481
Heist-op-den-Berg · Eq €217.06M
Of 148 companies in sector 21201 we hold annual accounts for 116. 10 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded09-09-1960
Fiscal year end30-11
Activities, NACEBEL 2025
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods
Scores and ratios are computed by Checked and are not a credit decision.